Zurueck zur Suche

Reporte zur Charge U013036

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

18Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 3 PA 2 TN 2 KY 2 IL 2 MD 2 NC 1 MI 1 VA 1 NJ 1

VAERS 2418387

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U013036

schwer
Staat
PA
Alter
17,0
Geschlecht
F
Eingang
23.08.2022
Impfdatum
23.08.2022
Beginn
23.08.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Syncope

Symptomtext

17 year old female became syncopal 10 minutes after injection. Recovered with fluids and food.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2409949

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U013036

schwer
Staat
TN
Alter
1,3
Geschlecht
F
Eingang
12.08.2022
Impfdatum
09.08.2022
Beginn
10.08.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Febrile convulsion Laboratory test

Symptomtext

Febrile seizure at 3:10 am lasting 2 minutes per dad report. Patient remained conscious, did not suffer from injury. Emergency medical services were called and patient's vitals were normal (values not known) per dad report.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Febrile convulsion
Hospital-Tage
-
Labordaten
Seen in primary care clinic 8/10/22, neurological tests performed, patient was alert, awake, and oriented, happy and smiling. No laboratory or medical tests beyond physical examination or vital completed.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2714711

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U013036

moderat
Staat
KY
Alter
20,0
Geschlecht
F
Eingang
16.11.2023
Impfdatum
01.03.2022
Beginn
11.10.2023
Tage bis Beginn
589,0
Dosis
2
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Condition aggravated Eczema Exposure to communicable disease Herpes zoster Inappropriate schedule of product administration Infection Stress

Symptomtext

I developed shingles at age 21 on October 11th, 2023. I never had chicken pox as a child. I am in school, however I have been under much more stress in my life than I am right now. My immune system may be under stress from being exposed to everything at clinical in the hospital, but I?ve been in school since May 2022. I had a recent infection in the same area as the shingles came to, and right before developing shingles I finished a cycle of cephalosporins and topical triamcinolone at the same site as the shingles. These medications were for an eczema exacerbation that my doctor believed became infected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
-
Labordaten
Visual exam
Aktuelle Erkrankungen
None that I know of, but I received MMR at the same time as the varicella shot. I received only one varicella shot because school required I complete my childhood series (I got 1 of 2 as a child). I received TDAP and HepB vaccines around this time as well, also for nursing school.
Vorgeschichte
Eczema
Andere Medikamente
None; was taking Vitamin C supplements
Allergien
Chest pain if I eat salmon
Vorherige Impfungen
-

VAERS 2370579

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U013036

mild
Staat
TX
Alter
49,0
Geschlecht
F
Eingang
15.07.2022
Impfdatum
15.07.2022
Beginn
15.07.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Muscular weakness Nausea

Symptomtext

became nauseated, right arm feeling weak

Weitere VAERSDATA-Felder
Praegender Schweregrund
Nausea
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
estrogen balancer, chlorphyl supplement
Allergien
-
Vorherige Impfungen
-

VAERS 2321915

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U013036

mild
Staat
NC
Alter
1,0
Geschlecht
F
Eingang
16.06.2022
Impfdatum
19.05.2022
Beginn
14.06.2022
Tage bis Beginn
26,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blister Otitis media Rash Rash pruritic Rash vesicular Urticaria

Symptomtext

Rash developed, blisters on bilateral legs. Rash very itchy. Diagnosed as Varicella rash

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
otitis media and urticaria 6/10/22
Vorgeschichte
none
Andere Medikamente
Amoxicillin Triamcinolone ointment
Allergien
none
Vorherige Impfungen
-

VAERS 2187526

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U013036

mild
Staat
IL
Alter
30,0
Geschlecht
F
Eingang
18.03.2022
Impfdatum
16.03.2022
Beginn
16.03.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pruritus Urticaria

Symptomtext

Generalized pruritic urticaria (Hives)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
nka
Vorherige Impfungen
-

VAERS 2645141

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U013036

gering
Staat
MD
Alter
-
Geschlecht
U
Eingang
14.06.2023
Impfdatum
23.05.2023
Beginn
23.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE; patient received MMR II expired 4/23/2023.; This spontaneous report was received from an other health professional and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 23-MAY-2023, the patient was vaccinated with expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant human albumin (rHa) (M-M-R II) injection, lot #U013036, expiration date 23-APR-2023 and administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided) (Expired product administered). No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2637491

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u013036

gering
Staat
PA
Alter
-
Geschlecht
U
Eingang
26.05.2023
Impfdatum
15.05.2023
Beginn
01.10.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event

Symptomtext

No additional AEs were reported; An expired MMR II was administered to a patient. MMR II had a temperature excursion in 10/2022 and it was given on 5/15/2023. The diluent did not have temperature excursion and was not expired. No additional AEs were reported. No further inform; MMR II had a temperature excursion in 10/2022; Description: An expired MMR II was administered to a patient. MMR II had a temperature excursion in 10/2022 and it was given on 5/15/2023. The diluent did not have temperature excursion and was not expired. No additional AEs were reported. No further information provided. No PQC. This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. The patient's historical medications, medical history, concurrent conditions and concomitant medications were not reported. In October 2022, the vaccine measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA)(M-M-R II) lot number u013036, expiration date 23-APR-2023 had a temperature excursion and was administered on 15-MAY-2023 (dose and route of administration not reported)(product storage error and expired product administered). The sterile diluent used to reconstitute the vaccine had no excursions and was no expired. No adverse event was reported. The excursion was of 50 degrees Fahrenheit for 4 hours. No previous excursions were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2575937

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U013036

gering
Staat
IL
Alter
41,0
Geschlecht
F
Eingang
04.02.2023
Impfdatum
03.02.2023
Beginn
03.02.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered at inappropriate site

Symptomtext

Grad intern gave IM vs Subq as recommended by manufacture

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered at inappropriate site
Hospital-Tage
-
Labordaten
unknown
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2574345

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U013036

gering
Staat
KY
Alter
4,0
Geschlecht
F
Eingang
02.02.2023
Impfdatum
30.01.2023
Beginn
01.01.2023
Tage bis Beginn
-
Dosis
UNK
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

Child was given Kinrix instead of DTAP and was also given IPOL on the same date. No known reactions from patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Hydrocortisone 2.5% topical cream
Allergien
No known
Vorherige Impfungen
-

VAERS 2522213

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U013036

gering
Staat
MI
Alter
17,0
Geschlecht
M
Eingang
02.12.2022
Impfdatum
10.11.2022
Beginn
10.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported.; MMR II and VARIVAX that had undergone temperature excursion was administered to a patient; This spontaneous report was received from a Certified Medical Assistant concerning a 17-year-old male patient. Their concurrent conditions, medical history, drug reactions/allergies, and concomitant medications were not provided. On 10-NOV-2022, the patient was vaccinated with an improperly storage dose varicella virus vaccine live (Oka/Merck) (VARIVAX) administered as prophylaxis, lot number U029496 with expiration date 21-SEP-2023 (dosage regimen and route of administration were not reported), and Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live recombinant human albumin (rHA) (M-M-R II) administered as prophylaxis, lot number U013036 with expiration date 23-APR-2023 (dosage regimen and route of administration were not reported). The vaccines underwent a temperature excursion of -10 C up to 8 C (0.1 C) for 444 hours minutes and 0 seconds, with a previous temperature excursion of -10 C up to 8 C (-7.2 C) for 7 hours 54 minutes and 0 seconds (Product storage error). No additional adverse events were reported (No adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2428184

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U013036

gering
Staat
VA
Alter
18,0
Geschlecht
M
Eingang
02.09.2022
Impfdatum
02.09.2022
Beginn
02.09.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration No adverse event

Symptomtext

Patient came to pharmacy to get his second dose of MMR. Medication was mixed properly but given IM instead of SQ. Patient had no known adverse event. Patient did not stay in store for 15 minutes after shot but called the store later and told a technician he was fine. Technician told him to stay on the phone because pharmacist wanted to speak with him but he hung up. Could not call patient back because he didn't leave his number.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None listed
Vorgeschichte
None listed
Andere Medikamente
Unknown
Allergien
NKA
Vorherige Impfungen
-

VAERS 2418261

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U013036

gering
Staat
TX
Alter
16,0
Geschlecht
M
Eingang
23.08.2022
Impfdatum
17.08.2022
Beginn
17.08.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

Adult TD was in advertently given to wrong age group. Patient did not experience any adverse symptoms or reactions. Monitored the patient for 15 minutes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2405656

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u013036

gering
Staat
TN
Alter
3,0
Geschlecht
F
Eingang
09.08.2022
Impfdatum
27.07.2022
Beginn
27.07.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Unevaluable event

Symptomtext

n/a

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
none
Vorherige Impfungen
-

VAERS 2328925

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U013036

gering
Staat
-
Alter
56,0
Geschlecht
F
Eingang
23.06.2022
Impfdatum
10.06.2022
Beginn
10.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect route of product administration No adverse event

Symptomtext

IM injection given SC route. patient was observed for 45 minutes; no adverse event occurred;

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2264211

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U013036

gering
Staat
NJ
Alter
-
Geschlecht
U
Eingang
05.05.2022
Impfdatum
21.04.2022
Beginn
21.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No adverse effects; Caller is an office manager who reports administration of vaccine following temperature excursion. No adverse effects of administration. No further information provided. No other AE/no PQC. ? Names of vaccines involved (including lot/exp; This spontaneous report was received from an office manager referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided. On 21-APR-2022, the patient was vaccinated with an improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA)(M-M-R II) 0.5 milliliter, lot number U013036, expiration date 23-APR-2023 for prophylaxis (route of administration not reported) (product storage error). The vaccine was reconstituted with sterile diluent that did not experienced any temperature excursion. no adverse event was reported. The vaccine underwent a temperature excursion of 14.5 degrees Celsius for 10 hours. No previous temperature excursions were detected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2225596

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U013036

gering
Staat
MD
Alter
1,0
Geschlecht
U
Eingang
11.04.2022
Impfdatum
04.04.2022
Beginn
04.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other issues or concerns noted; MMRII had a TE and had been administered; This spontaneous report was received from a medical assistant referring to a 12-month-old patient of unknown gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided. On an unknown date, measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) experienced temperature excursion with 47 Fahrenheit degrees for 6 minutes and 50 seconds. On 04-APR-2022, the patient was vaccinated with the improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (rHA) (lot # U013036, expiration date 23-APR-2023; strength, dose, route of administration and anatomical location were not reported) for prophylaxis (product storage error). No other adverse event (AE) or product quality complaint (PQC) was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2131236

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U013036

gering
Staat
TX
Alter
4,0
Geschlecht
M
Eingang
22.02.2022
Impfdatum
22.02.2022
Beginn
22.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Petechiae

Symptomtext

Clinically stable and asymptomatic. Found to have a faint petechial rash around his forehead and BL cheeks without mucosal involvement. Mother stated that rash developed about 30 minutes after vaccinations administered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Petechiae
Hospital-Tage
-
Labordaten
CBC ordered within 1 hour.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-